Faro Capital

Bionamic specializes in streamlining life science data analysis by automating manual steps between raw data and results. Its platform serves as a centralized hub for antibody-related discovery and development data, empowering researchers to navigate and interpret their data effectively.

IntuiCell is a technology company focused on developing innovative brain intelligence solutions that leverage a unique recursive computing architecture. This architecture enables the company to tackle both tractable and intractable challenges using artificial intelligence. IntuiCell's technology can operate on existing hardware platforms or as standalone applications, requiring no external computational support. This adaptability allows various industries to enhance the functionality of consumer-level electronics, addressing a wide range of challenges and improving overall performance.

SAGA Diagnostics AB is a Swedish company specializing in personalized cancer diagnostics and disease monitoring through molecular genetic analyses, focusing on circulating tumor DNA (ctDNA). Founded in 2016 as a spin-out from a research group at Lund University, SAGA aims to enhance precision cancer medicine and improve patient survival rates with its minimally-invasive liquid biopsy testing services. The company provides a range of services, including gene mutation analysis and treatment monitoring, utilizing advanced technologies such as massively parallel sequencing. SAGA's proprietary tests enable oncologists and biopharmaceutical companies to detect actionable mutations, stratify patient groups, and monitor treatment responses with high sensitivity, thereby contributing significantly to advancements in cancer research and clinical diagnostics.

Aligned Bio specializes in developing advanced biosensor platforms using patented nanowire production methods. Their sensors are designed for applications such as biomedicine, water purification, public safety, and electronics, offering high sensitivity, accuracy, and speed.